Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Seminars in Liver Disease · 2023-05 · 43 (02) · 149-162
DOI: 10.1055/s-0043-57237 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, online erschienen am 08.05.2023. Verfasst von Monika Adori und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Abbreviations graphical abstract: VMN/PVN, hypothalamic ventromedial nucleus/paraventricular nucleus; VLM/VMM, ventrolateral medulla/ventromedial medulla; SMG/CG, superior mesenteric ganglion/caeliac ganglia; NTS, nucleus of the solitary tract; NG, nodose ganglion. Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder. Increased sympathetic (noradrenergic) nerve tone has a complex role in the etiopathomechanism of NAFLD, affecting the development/progression of steatosis, inflammation, fibrosis, and liver hemodynamical alterations. Also, lipid sensing by vagal afferent fibers is an important player in the development of hepatic steatosis. Moreover, disorganization and progressive degeneration of liver sympathetic nerves were recently described in human and experimental NAFLD. These structural alterations likely come along with impaired liver sympathetic nerve functionality and lack of adequate hepatic noradrenergic signaling. Here, we first overview the anatomy and physiology of liver nerves. Then, we discuss the nerve impairments in NAFLD and their pathophysiological consequences in hepatic metabolism, inflammation, fibrosis, and hemodynamics. We conclude that further studies considering the spatial-temporal dynamics of structural and functional changes in the hepatic nervous system may lead to more targeted pharmacotherapeutic advances in NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
- Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Molecular Medicine and Surgery, The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Stockholm, Sweden.
- Department of Molecular Biosciences, The Wenner-Gren Institute (MBW), Stockholm University, Stockholm, Sweden.
- Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Zitieren
APA
Adori, M., Bhat, S., Gramignoli, R., Valladolid-Acebes, I., Bengtsson, T., Uhlèn, M., & Adori, C. (2023). Hepatic Innervations and Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease, 43(02), 149-162. https://doi.org/10.1055/s-0043-57237
Vancouver
Adori M, Bhat S, Gramignoli R, Valladolid-Acebes I, Bengtsson T, Uhlèn M, et al. Hepatic Innervations and Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease. 2023;43(02):149-162. doi:10.1055/s-0043-57237
BibTeX
@article{Adori2023,
author = {Adori, Monika and Bhat, Sadam and Gramignoli, Roberto and Valladolid-Acebes, Ismael and Bengtsson, Tore and Uhlèn, Mathias and Adori, Csaba},
title = {Hepatic Innervations and Nonalcoholic Fatty Liver Disease},
journal = {Seminars in Liver Disease},
year = {2023},
volume = {43},
number = {02},
pages = {149--162},
doi = {10.1055/s-0043-57237}
}
EUVIMED